Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07689864 · ClinicalTrials.gov registry record
Unified Network for Integrated Fluid Collection at Yale
A clinical trial, sponsored by Yale University.
- Not yet
- Registry status
- 2,500
- Enrollment target
NCT07689864: Clinical Trial study, sponsored by Yale University.
NCT07689864 is a clinical trial that has not yet begun recruiting, run by Yale University. The registered enrollment target is 2,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07689864 has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
Study Summary
UNIFY is a Yale-wide liquid biopsy master repository that prospectively collects Streck-tube blood, dried blood spots (and optional archival tissue) from Yale Cancer Center patients across all tumor types for current and future research.
Primary Outcome
Facilitate and streamline the collection, banking, and clinical annotation of liquid biopsy biospecimens (peripheral blood collected in Streck Cell-Free DNA BCT® tubes or blood spots) - and, optionally, corresponding archival tumor specimens - for cancer research studies across Yale Cancer Center and the Smilow Cancer Hospital network.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2026-08 |
| Est. Completion | 2031-08 |
What is known before NCT07689864 opens enrollment
NCT07689864 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT07689864 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07689864 about?
NCT07689864 is a clinical study titled "Unified Network for Integrated Fluid Collection at Yale". UNIFY is a Yale-wide liquid biopsy master repository that prospectively collects Streck-tube blood, dried blood spots (and optional archival tissue) from Yale Cancer Center patients across all tumor types for current and future research.
What is the current status of trial NCT07689864?
This trial is currently not yet recruiting. The enrollment target is 2,500 participants. The study started on 2026-08. Estimated completion is 2031-08.
Who is sponsoring clinical trial NCT07689864?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia